Prevalence, Treatment Patterns, and Outcomes of Individuals with EGFR Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion EGFR Mutation Carriers

Real-world evidence surrounding EGFR positive NSCLC patients in Canada is limited. Administrative databases in Alberta, Canada were used to evaluate EGFR testing and mutation prevalence in de novo metastatic NSCLC, as well as the characteristics, treatment patterns, and outcomes of individuals with...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Sullivan, Dylan E., Jarada, Tamer N., Yusuf, Amman, Hu, Leo (Xun Yang), Gogna, Priyanka, Brenner, Darren R., Abbie, Erica, Rose, Jennifer B., Eaton, Kiefer, Elia-Pacitti, Julia, Ewara, Emmanuel M., Pabani, Aliyah, Cheung, Winson Y., Boyne, Devon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600059/
https://www.ncbi.nlm.nih.gov/pubmed/36290844
http://dx.doi.org/10.3390/curroncol29100567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600059/
https://www.ncbi.nlm.nih.gov/pubmed/36290844
http://dx.doi.org/10.3390/curroncol29100567

Ejemplares similares